KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Treasury Shares: 2012-2024

Historic Treasury Shares for Jazz Pharmaceuticals (JAZZ) over the last 8 years, with Dec 2024 value amounting to $4.0 million.

  • Jazz Pharmaceuticals' Treasury Shares rose 13.19% to $4.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.0 million, marking a year-over-year increase of 13.19%. This contributed to the annual value of $4.0 million for FY2024, which is 13.19% up from last year.
  • According to the latest figures from Q4 2024, Jazz Pharmaceuticals' Treasury Shares is $4.0 million, which was up 44.04% from $2.8 million recorded in Q3 2024.
  • In the past 5 years, Jazz Pharmaceuticals' Treasury Shares registered a high of $4.0 million during Q4 2024, and its lowest value of $800,000 during Q2 2023.
  • Its 3-year average for Treasury Shares is $2.5 million, with a median of $2.8 million in 2024.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Treasury Shares declined by 20.00% in 2020, and later soared by 115.38% in 2024.
  • Jazz Pharmaceuticals' Treasury Shares (Quarterly) stood at $1.9 million in 2020, then surged by 40.10% to $2.6 million in 2021, then rose by 21.97% to $3.2 million in 2022, then rose by 11.03% to $3.6 million in 2023, then climbed by 13.19% to $4.0 million in 2024.
  • Its Treasury Shares stands at $4.0 million for Q4 2024, versus $2.8 million for Q3 2024 and $1.5 million for Q2 2024.